Article
Canaccord Genuity Maintains Buy on Compass Pathways, Raises Price Target to $20
Canaccord Genuity analyst Sumant Kulkarni maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the price target from $15 to $20.
Comments
- No comments yet. Be the first to comment!